Outset Medical, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $119.5M | $113.7M | $130.4M | $115.4M | $102.6M | $49.9M | $15.1M | $2.0M |
| Cost of Revenue | $72.7M | $75.1M | $101.4M | $97.5M | $95.0M | $63.0M | $32.9M | $8.1M |
| Gross Profit | $46.8M | $38.6M | $29.0M | $17.8M | $7.6M | $-13.0M | $-17.8M | $-6.1M |
| Gross Margin | 39.1% | 33.9% | 22.2% | 15.5% | 7.4% | -26.1% | -118.1% | -304.7% |
| Operating Expenses | ||||||||
| Research & Development | $21.2M | $38.4M | $57.3M | $48.9M | $36.7M | $28.9M | $23.3M | $22.9M |
| SG&A Expense | $37.9M | $43.5M | $45.2M | $40.5M | $36.3M | $30.5M | $8.9M | $6.3M |
| Operating Income | $-66.7M | $-113.4M | $-169.8M | $-161.0M | $-130.5M | $-117.5M | $-70.3M | $-46.6M |
| Operating Margin | -55.8% | -99.7% | -130.2% | -139.6% | -127.2% | -235.2% | -466.3% | -2,320.0% |
| Interest Expense | $14.0M | $23.9M | $12.7M | $3.6M | $1.7M | $2.9M | $4.3M | $4.6M |
| Pretax Income | $-80.9M | $-127.5M | $-172.3M | $-162.7M | $-131.7M | $-121.5M | $-68.3M | $-49.8M |
| Income Tax Expense | $718.0K | $491.0K | $523.0K | $295.0K | $199.0K | $0 | $20.0K | $25.0K |
| Net Income | $-81.7M | $-128.0M | $-172.8M | $-163.0M | $-131.9M | $-121.5M | $-68.3M | $-49.8M |
| Net Margin | -68.3% | -112.6% | -132.5% | -141.2% | -128.6% | -243.3% | -453.0% | -2,480.3% |
| EPS (Basic) | $-5.37 | $-9.24 | $-13.07 | $-0.85 | $-0.72 | $-0.40 | $-8.30 | $-8.40 |
| EPS (Diluted) | $-5.37 | $-9.24 | $-13.07 | $-0.85 | $-0.72 | $-0.40 | $-8.30 | $-8.40 |
| Shares Outstanding (Basic) | 15.2K | 13.9K | 13.2K | 192.6K | 182.4K | 196.3K | 11.1M | — |
| Shares Outstanding (Diluted) | 15.2K | 13.9K | 13.2K | 192.6K | 182.4K | 196.3K | 11.1M | — |
| Dividends Per Share | — | — | — | — | — | — | — | — |